The device company’s orthopedic reconstructive business and extremities business totaled $59.5 million and $50.9 million, respectively. These totals represent a 12.2 percent loss and a 0.8 percent gain, respectively.
More Articles on Orthopedic Devices:
Alphatec Spine 3Q Revenue Drops 1.6%
Amedica Names Jay Moyes to Board of Directors
Globus Medical 3Q Worldwide Sales Reach $94.8M, Up 12.5%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.